2476-213X

Journal of Clinical Infectious Diseases & Practice
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Clin Infect Dis Pract 2023, Vol 8(3): 186
  • DOI: 10.4172/2476-213X.1000186

Revolutionizing Infectious Disease Diagnosis: Anti-Idiotype Antibodies at the Forefront

Gardner Christina*
Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden
*Corresponding Author : Gardner Christina, Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden, Email: Christinagardner@cz.sd

Received Date: May 02, 2023 / Published Date: May 30, 2023

Abstract

Immunoassays for infectious pathogens include the traditional radioimmunoassay and the more recent enzymelinked immunosorbent assay (ELISA). This allows numerous different configurations of antigen and antibody. Most immune assays use primary antibodies directed against specific epitopes of the infectious agent; the amount of primary antibody bound via a second antibody subsequently is quantitated by tagging with an easily identifiable marker. Effective immunoassays for certain infectious agents have been very difficult to develop, prompting investigators to search for alternatives in the design of rapid immunological tests.

Citation: Christina G (2023) Revolutionizing Infectious Disease Diagnosis: Anti- Idiotype Antibodies at the Forefront. J Clin Infect Dis Pract, 8: 187. Doi: 10.4172/2476-213X.1000186

Copyright: © 2023 Christina G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top